Cargando…
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix †
Therapeutic vaccinations aim to re-educate human immunodeficiency virus (HIV)-1-specific immune responses to achieve durable control of HIV-1 replication in virally suppressed infected individuals after antiretroviral therapy (ART) is interrupted. In a double blinded, placebo-controlled phase IIa mu...
Autores principales: | de Jong, Wesley, Leal, Lorna, Buyze, Jozefien, Pannus, Pieter, Guardo, Alberto, Salgado, Maria, Mothe, Beatriz, Molto, Jose, Moron-Lopez, Sara, Gálvez, Cristina, Florence, Eric, Vanham, Guido, van Gorp, Eric, Brander, Christian, Allard, Sabine, Thielemans, Kris, Martinez-Picado, Javier, Plana, Montserrat, García, Felipe, Gruters, Rob A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963294/ https://www.ncbi.nlm.nih.gov/pubmed/31817794 http://dx.doi.org/10.3390/vaccines7040209 |
Ejemplares similares
-
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019) -
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
por: de Jong, Wesley, et al.
Publicado: (2019) -
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
por: Leal, Lorna, et al.
Publicado: (2018) -
HTI
por: Main, Max
Publicado: (2004) -
Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
por: Saubi, Narcís, et al.
Publicado: (2020)